Sat.Oct 24, 2020 - Fri.Oct 30, 2020

article thumbnail

Pharma 2030: Will payers fund more preventive care programmes?

pharmaphorum

Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new analysis looks at these barriers and asks how they could be overcome. Over the past decade, many healthcare systems have worked to expand their focus on health maintenance and disease prevention as several studies have indicated that preventive care services can play a significant role in improving general health while helping reduce long term healthcare costs.

Vaccines 130
article thumbnail

IQVIA: tap the right talent to lead digital transformation

Outsourcing Pharma

In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.

126
126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

90@90 Video… The New Now

Pharma Marketing Network

October 22, 2020 eHealthcare Solutions hosted their 90@90 webinar, Video…The New Now. Throughout the webinar, EVP, Partner Development of eHealthcare Solutions, Gail Jaeger-Law, covers three different topics including, what has changed and what has remained the same during COVID-19, the current state of the industry including shifts and changes, and growth in the digital landscape including video.

52
article thumbnail

Why Sneeze Guards are Not Optional Anymore

Pharma Mirror

The sneeze guard has been keeping employees at public counters, and food on display, safe from contagious diseases for a long time now, so it’s most certainly not a new invention. However, the need to install a sneeze guard in hospitals, pharmacies and other healthcare facilities is an absolute must in 2020 and beyond. Keeping. The post Why Sneeze Guards are Not Optional Anymore appeared first on Pharma Mirror Magazine.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ipsen’s UK MD on adapting business to COVID-19

pharmaphorum

Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop

Hospitals 126
article thumbnail

FDA okays first COVID-19 treatment

Outsourcing Pharma

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

FDA 105

More Trending

article thumbnail

Temperature monitoring solutions provider TSS shares news on new appointment for Middle East operations

Pharma Mirror

Leading cloud temperature management solutions provider, TSS Middle East, today announces the appointment of Christopher Hobeiche as the new regional manager for their Middle East operations. Christopher Hobeiche joined the TSS Middle East Africa team earlier this month as part of strategic efforts to strengthen company operations in the region. TSS provides temperature monitoring solutions.

52
article thumbnail

Why 72% of patients don’t feel listened to by pharma

pharmaphorum

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Vaccines 119
article thumbnail

Enosi: COVID-19 adds to autoimmune challenges

Outsourcing Pharma

A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.

105
105
article thumbnail

Calamine lotion for chickenpox skin itchiness

Druggist

Calamine lotion for chickenpox is usually considered the first choice in the management of itchiness caused by varicella-zoster virus infection. Calamine lotion is cheap and widely available. In this post, I will review the use of calamine lotion for chickenpox. Summary of this post: What is calamine lotion? Is calamine lotion effective for chickenpox rush?

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Cognitive function boosted in MCI patients, with new ketogenic drink

Pharma Mirror

New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has established people with Mild Cognitive Impairment (MCI) experienced significant improvement in cognitive function when consuming a specialized ketogenic drink (BrainXpert Energy Complex) twice a day for six months.

52
article thumbnail

What can we learn from women’s health data?

pharmaphorum

Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.

article thumbnail

CRAACO event unites clinical research and care

Outsourcing Pharma

This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.

article thumbnail

Saw Palmetto With Finasteride

Med Ed 101

I’ve been asked by patients before if they can take saw palmetto with finasteride. Here’s my thought process based upon a case scenario. JS is a 71-year-old male who presents to his annual physical. He is reporting worsening symptoms involving his urinary tract. He says he has to go to the bathroom a lot and […]. The post Saw Palmetto With Finasteride appeared first on Med Ed 101.

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Becoming a Woman of Impact: Success Stories from HBA Women of the Year

Pharma Marketing Network

Sponsored by GSK’s Women’s Leadership Initiative. Recently, the HBA Mid-Atlantic Region held a webinar called, Becoming a Woman of Impact , where four Women of the Year award winners shared stories of the lessons they have learned throughout their careers and advice to help others accelerate their own career growth. The panel, moderated by Amy Turnquist, President, HBA Philadelphia, included, 2020 Woman of the Year , Sandra J.

40
article thumbnail

Moderna nears COVID-19 vaccine finish line as it wraps up study enrolment

pharmaphorum

Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial. It’s also revealed that more than 25,000 of them have already received the second dose of the shot in the COVE study , putting it in contention to be the first coronavirus vaccine company to be ready to file for emergency use authorisation in the US.

Vaccines 111
article thumbnail

Care Access Research, Lilly join on mobile COVID-19 trials

Outsourcing Pharma

The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.

98
article thumbnail

Oxford start-up Base Genomics acquired by Exact Sciences

Pharma Times

Acquisition will enable Base Genomics to accelerate clinical and commercial development

58
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Ep. 009 – Robin Farmanfarmaian Podcast Transcript. Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. I’m your host Don Langsdorf and we’ve got a great guests lined up for you today her name is Robin Farmanfarmaian she’s a professional speaker and entrepreneur based in Silicon Valley. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health.

article thumbnail

NIAID drops Lilly antibody from ACTIV-3 COVID-19 trial

pharmaphorum

Eli Lilly says no more patients will be treated with its COVID-19 therapy bamlanivimab in a trial run by the US National Institute of Allergy and Infectious Diseases (NIAID), as results to date suggest it is unlikely to be effective. The ACTIV-3 study was comparing bamlanivimab (also known as LY-CoV555 or LY3819253) and placebo when added to therapy with Gilead Sciences’ Veklury (remdesivir), which is already approved to treat COVID-19 requiring hospitalisation.

article thumbnail

Elligo: clinical trials can learn from healthcare

Outsourcing Pharma

During the CRAACO conference, a leader from the study solutions firm will discuss how researchers can learn and benefit from the other industry.

98
article thumbnail

UK biotech consortium identifies COVID-19 antibody combinations

Pharma Times

The UK BIA Antibody Taskforce is set to take combinations into further development as a cocktail

49
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Ep. 009 – Robin Farmanfarmaian Podcast Transcript. Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. I’m your host Don Langsdorf and we’ve got a great guests lined up for you today her name is Robin Farmanfarmaian she’s a professional speaker and entrepreneur based in Silicon Valley. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health.

article thumbnail

US buys Lilly COVID antibody, as effectiveness questions remain

pharmaphorum

The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness has been called into question. The initial agreement is for delivery over the two months following an EUA, and provides the option for the government to purchase up to an additional 650,000 vials through 30 June 2021.

article thumbnail

Roche, Atea Pharmaceuticals partner on COVID-19 oral treatment

Outsourcing Pharma

The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.

57
article thumbnail

AZ’s Fasenra hits the mark in phase IIIb asthma trial

Pharma Times

Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients

49
article thumbnail

Top Considerations for Data Protection and Cybersecurity within the Pharmaceutical Industry

Pharma Marketing Network

The pharmaceutical industry deals with copious amounts of personal data, which means that adequate data protection and cybersecurity are non-negotiable. Even two years after the introduction of the General Data Protection Regulation (GDPR), the Information Commissioner Office is still fining companies who fail to fully protect their data. There are two sides of the data protection issue facing the pharma industry.

article thumbnail

COVID-19 bites into Pfizer’s Q3, but biopharma revenues rise

pharmaphorum

Pfizer is one of the front-runners in the race to approve a COVID-19 vaccine but the US company has had to weather lower revenues for the third quarter due to the ongoing impacts of COVID-19. Despite the decline, biopharma revenues increased overall. Total third-quarter 2020 revenues hit $12.1 billion, a decrease of $549 million, or 4%, compared to last year.

Vaccines 104
article thumbnail

Inteliquet: COVID-19 transforming oncology trial landscape

Outsourcing Pharma

A leader from the cancer patient matching and analysis solutions firm discusses how and other forces are pushing innovation in the oncology research space.

52
article thumbnail

Parkinson’s UK partners with UCL on phase II trial

Pharma Times

Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s

article thumbnail

Best PAIN RELIEVER for toothache

Druggist

In a pharmacy, patients request a pain relief medication due to a toothache quite commonly. Seeing a dentist to investigate the cause of pain is crucial. In the meantime, the patient may consider the use of over the counter medicines to manage the pain. Although it is difficult to point out a single best pain reliever for toothache, patients may see pain reduction with any of the drugs reviewed below.

article thumbnail

BioSig abandons COVID-19 drug trial on safety concerns

pharmaphorum

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Shares in the company plunged more than 40% on the Nasdaq after the announcement, which revealed a difference in survival rates between the two groups enrolled into the study.

article thumbnail

Bio-Optronics upgrades eConsent solution

Outsourcing Pharma

The company has introduced a number of upgraded features to its CCeConsent eSignature, intended to boost user effectiveness and patient convenience.

52
article thumbnail

AstraZeneca resumes US phase III COVID-19 vaccine trial

Pharma Times

Trial was paused in September following participant illness